DHR
Price
$201.00
Change
+$3.53 (+1.79%)
Updated
Jun 25 closing price
Capitalization
184.93B
26 days until earnings call
IQV
Price
$158.71
Change
+$0.13 (+0.08%)
Updated
Jun 25 closing price
Capitalization
45.3B
33 days until earnings call
Interact to see
Advertisement

DHR vs IQV

Header iconDHR vs IQV Comparison
Open Charts DHR vs IQVBanner chart's image
Danaher
Price$201.00
Change+$3.53 (+1.79%)
Volume$4.38M
Capitalization184.93B
IQVIA Holdings
Price$158.71
Change+$0.13 (+0.08%)
Volume$2.09M
Capitalization45.3B
DHR vs IQV Comparison Chart in %
Loading...
DHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IQV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DHR vs. IQV commentary
Jun 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DHR is a StrongBuy and IQV is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 26, 2025
Stock price -- (DHR: $201.00 vs. IQV: $158.71)
Brand notoriety: DHR: Not notable vs. IQV: Notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: DHR: 106% vs. IQV: 86%
Market capitalization -- DHR: $184.93B vs. IQV: $45.3B
DHR [@Medical Specialties] is valued at $184.93B. IQV’s [@Medical Specialties] market capitalization is $45.3B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DHR’s FA Score shows that 0 FA rating(s) are green whileIQV’s FA Score has 0 green FA rating(s).

  • DHR’s FA Score: 0 green, 5 red.
  • IQV’s FA Score: 0 green, 5 red.
According to our system of comparison, IQV is a better buy in the long-term than DHR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DHR’s TA Score shows that 6 TA indicator(s) are bullish while IQV’s TA Score has 4 bullish TA indicator(s).

  • DHR’s TA Score: 6 bullish, 4 bearish.
  • IQV’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, DHR is a better buy in the short-term than IQV.

Price Growth

DHR (@Medical Specialties) experienced а +3.37% price change this week, while IQV (@Medical Specialties) price change was +2.65% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.79%. For the same industry, the average monthly price growth was +2.12%, and the average quarterly price growth was -0.19%.

Reported Earning Dates

DHR is expected to report earnings on Jul 22, 2025.

IQV is expected to report earnings on Jul 29, 2025.

Industries' Descriptions

@Medical Specialties (+0.79% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DHR($185B) has a higher market cap than IQV($45.3B). DHR has higher P/E ratio than IQV: DHR (43.86) vs IQV (34.14). DHR YTD gains are higher at: -12.304 vs. IQV (-19.236). DHR has higher annual earnings (EBITDA): 7.5B vs. IQV (3.26B). DHR has more cash in the bank: 5.86B vs. IQV (1.5B). IQV has less debt than DHR: IQV (13.9B) vs DHR (19.5B). DHR has higher revenues than IQV: DHR (23.9B) vs IQV (15B).
DHRIQVDHR / IQV
Capitalization185B45.3B408%
EBITDA7.5B3.26B230%
Gain YTD-12.304-19.23664%
P/E Ratio43.8634.14128%
Revenue23.9B15B159%
Total Cash5.86B1.5B392%
Total Debt19.5B13.9B140%
FUNDAMENTALS RATINGS
DHR vs IQV: Fundamental Ratings
DHR
IQV
OUTLOOK RATING
1..100
1218
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
71
Overvalued
PROFIT vs RISK RATING
1..100
6291
SMR RATING
1..100
7842
PRICE GROWTH RATING
1..100
6059
P/E GROWTH RATING
1..100
7081
SEASONALITY SCORE
1..100
9585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DHR's Valuation (55) in the Medical Specialties industry is in the same range as IQV (71) in the Servicestothe Health Industry industry. This means that DHR’s stock grew similarly to IQV’s over the last 12 months.

DHR's Profit vs Risk Rating (62) in the Medical Specialties industry is in the same range as IQV (91) in the Servicestothe Health Industry industry. This means that DHR’s stock grew similarly to IQV’s over the last 12 months.

IQV's SMR Rating (42) in the Servicestothe Health Industry industry is somewhat better than the same rating for DHR (78) in the Medical Specialties industry. This means that IQV’s stock grew somewhat faster than DHR’s over the last 12 months.

IQV's Price Growth Rating (59) in the Servicestothe Health Industry industry is in the same range as DHR (60) in the Medical Specialties industry. This means that IQV’s stock grew similarly to DHR’s over the last 12 months.

DHR's P/E Growth Rating (70) in the Medical Specialties industry is in the same range as IQV (81) in the Servicestothe Health Industry industry. This means that DHR’s stock grew similarly to IQV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DHRIQV
RSI
ODDS (%)
Bearish Trend 1 day ago
65%
Bearish Trend 1 day ago
64%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
62%
Bearish Trend 1 day ago
63%
Momentum
ODDS (%)
Bearish Trend 1 day ago
62%
Bearish Trend 1 day ago
62%
MACD
ODDS (%)
Bullish Trend 1 day ago
64%
Bullish Trend 1 day ago
60%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
59%
Bullish Trend 1 day ago
63%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
56%
Bullish Trend 1 day ago
65%
Advances
ODDS (%)
Bullish Trend 1 day ago
56%
Bullish Trend 1 day ago
60%
Declines
ODDS (%)
Bearish Trend 8 days ago
59%
Bearish Trend 24 days ago
62%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
58%
Bearish Trend 1 day ago
58%
Aroon
ODDS (%)
Bullish Trend 1 day ago
52%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
DHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IQV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NEGG12.230.36
+3.08%
Newegg Commerce Inc
GABC38.35-0.12
-0.31%
German American Bancorp
BCS18.17-0.09
-0.49%
Barclays PLC
HP15.48-0.46
-2.89%
Helmerich & Payne
MIGI0.42-0.03
-7.11%
Mawson Infrastructure Group

DHR and

Correlation & Price change

A.I.dvisor indicates that over the last year, DHR has been closely correlated with TMO. These tickers have moved in lockstep 80% of the time. This A.I.-generated data suggests there is a high statistical probability that if DHR jumps, then TMO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DHR
1D Price
Change %
DHR100%
+1.79%
TMO - DHR
80%
Closely correlated
+1.55%
RVTY - DHR
69%
Closely correlated
+1.36%
IQV - DHR
67%
Closely correlated
+0.08%
RGEN - DHR
67%
Closely correlated
+0.54%
A - DHR
65%
Loosely correlated
+0.83%
More